Cargando…

Efficacy and safety of therapeutic HPV vaccines to treat CIN 2/CIN 3 lesions: a systematic review and meta-analysis of phase II/III clinical trials

OBJECTIVES: We aim to assess the efficacy and safety of therapeutic human papillomavirus (HPV) vaccines to treat cervical intraepithelial neoplasia of grade 2 or 3 (CIN 2/3). DESIGN: Systematic review and meta-analysis, following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ibrahim Khalil, Ahmadaye, Zhang, Li, Muwonge, Richard, Sauvaget, Catherine, Basu, Partha
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10603536/ https://www.ncbi.nlm.nih.gov/pubmed/37879679 http://dx.doi.org/10.1136/bmjopen-2022-069616

Ejemplares similares

Progression of CIN1/LSIL HPV Persistent of the Cervix: Actual Progression or CIN3 Coexistence
por: Bruno, Maria Teresa, et al.
Publicado: (2021)

HPV-Testing in Follow-up of Patients Treated for CIN2+ Lesions
por: Mariani, Luciano, et al.
Publicado: (2016)

Evaluating HPV‐negative CIN2+ in the ATHENA trial
por: Petry, Karl Ulrich, et al.
Publicado: (2016)

CIN III lesions and regression: retrospective analysis of 635 cases
por: Motamedi, Melodi, et al.
Publicado: (2015)

Clearance of persistent HPV infection and cervical lesion by therapeutic DNA vaccine in CIN3 patients
por: Kim, Tae Jin, et al.
Publicado: (2014)

Bayesian analysis of baseline risk of CIN2 and ≥CIN3 by HPV genotype in a European referral cohort
por: Bonde, Jesper, et al.
Publicado: (2019)

The wages of CIN
por: Yuen, Karen W., et al.
Publicado: (2008)

The progress in our understanding of CIN in breast cancer research
por: Liao, Yu-Yang, et al.
Publicado: (2023)

Therapeutic vaccination using HPV 16 E7 to eradicate CIN3
por: Tewari, Krishnansu S.
Publicado: (2019)

CIN III Diagnosed following Surgical Termination of Pregnancy
por: Mackenzie, Ciara, et al.
Publicado: (2014)

Conservative management of CIN2 p16 positive lesions in women with multiple HPV infection
por: Bruno, Maria Teresa, et al.
Publicado: (2020)

HPV Tests Comparison in the Detection and Follow-Up after Surgical Treatment of CIN2+ Lesions
por: Bottari, Fabio, et al.
Publicado: (2022)

Tincture Cin Honœ Ferrata
por: Sims, Samuel
Publicado: (1853)

Underdiagnosis of cervical intraepithelial neoplasia (CIN) 2 or Worse Lesion in Women with a Previous Colposcopy-Guided Biopsy Showing CIN 1
por: Souza, Carlos André Scheler de, et al.
Publicado: (2017)

Can the prophylactic quadrivalent HPV vaccine be used as a therapeutic agent in women with CIN? A randomized trial
por: Karimi-Zarchi, Mojgan, et al.
Publicado: (2020)

Cytokine Release in HR-HPV(+) Women without and with Cervical Dysplasia (CIN II and III) or Carcinoma, Compared with HR-HPV([Formula: see text]) Controls
por: Bais, Aagje G., et al.
Publicado: (2007)

A new assay for measuring chromosome instability (CIN) and identification of drugs that elevate CIN in cancer cells
por: Lee, Hee-Sheung, et al.
Publicado: (2013)

Are CIN3 risk or CIN3+ risk measures reliable surrogates for invasive cervical cancer risk?
por: Austin, R. Marshall, et al.
Publicado: (2020)

Adjunctive use of p16 immunohistochemistry for optimizing management of CIN lesions in a high‐risk human papillomavirus‐positive population
por: Ebisch, Renée M. F., et al.
Publicado: (2022)

Clinical and analytical performance of the BD Onclarity™ HPV assay for detection of CIN2+ lesions on SurePath samples
por: Ejegod, Ditte Møller, et al.
Publicado: (2016)

Quantitative Histopathological Analysis of CIN Sections
por: Baak, Jan P. A.
Publicado: (2006)

Quantitative Histopathological Analysis of CIN Sections
por: Guillaud, Martial, et al.
Publicado: (2006)

Evolution of aneuploidy: overcoming the original CIN
por: Storchova, Zuzana
Publicado: (2018)

Up to your NEK2 in CIN
por: Seachrist, Darcie D., et al.
Publicado: (2021)

The adaptive strategies of cells in the face of CIN
por: Storchová, Zuzana
Publicado: (2023)

Chronical cervical infections and dysplasia (CIN I, CIN II): Vaginal vitamin D (high dose) treatment: A new effective method?
por: Schulte-Uebbing, C, et al.
Publicado: (2014)

Abnormal FHIT expression profiles in cervical intraepithelial neoplastic (CIN) lesions
por: Terry, G, et al.
Publicado: (2002)

HPV58 E7 Protein Expression Profile in Cervical Cancer and CIN with Immunohistochemistry
por: Zheng, Qiaoli, et al.
Publicado: (2021)

HPV16 variant analysis in primary and recurrent CIN2/3 lesions demonstrates presence of the same consensus variant
por: van der Weele, Pascal, et al.
Publicado: (2019)

Improving the Quality of Healthcare Provision Regarding HPV Immunization for Women with CIN2+ Lesions: The Experience of the Veneto Region in Italy
por: De Polo, Anna, et al.
Publicado: (2023)

Overexpression of programmed cell death ligand 1 in patients with CIN and its correlation with human papillomavirus infection and CIN persistence
por: Sancakli Usta, Ceyda, et al.
Publicado: (2020)

CIN2+ detection of the HPV DNA Array genotyping assay in comparison with the Cobas 4800 HPV test and cytology
por: Pesic, Aleksandra, et al.
Publicado: (2019)

p53 hides a multitude of CIN
por: Short, Ben
Publicado: (2010)

The CINs of Polo-Like Kinase 1 in Cancer
por: Cunningham, Chelsea E., et al.
Publicado: (2020)

The Regulation of CIN-like TCP Transcription Factors
por: Lan, Jingqiu, et al.
Publicado: (2020)

The Ed. Ef Cin. Med. Jour. Remarks
Publicado: (1889)

Apoptosis as a Barrier against CIN and Aneuploidy
por: Weiss, Johannes G., et al.
Publicado: (2022)

Risks of CIN 2+, CIN 3+, and Cancer by Cytology and Human Papillomavirus Status: The Foundation of Risk-Based Cervical Screening Guidelines
por: Demarco, Maria, et al.
Publicado: (2017)

Long-term CIN3+ risk in women with abnormal cytology; role of hrHPV testing
por: Kocken, M, et al.
Publicado: (2012)

Post-hysterectomy vaginal cuff cancer secondary to HPV infection and CIN: A case report
por: Liu, Xiaoxia, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_82pkfb5v802htm1uhdpsc0uknb